
-
Biomarin Pharmaceutical Inc. NASDAQ:BMRN BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
Location: 105 Digital Dr, California, 94949-8703, US | Website: www.biomarin.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
12.37B
Cash
1.138B
Avg Qtr Burn
N/A
Short % of Float
2.67%
Insider Ownership
0.96%
Institutional Own.
98.67%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Approved Quarterly sales | ||
VOXZOGO (vosoritide) Details Achondroplasia, Genetic Short Stature Conditions | Approved Quarterly sales | |
VOXZOGO (vosoritide) Details Achondroplasia, Genetic Short Stature Conditions | Approved Quarterly sales | |
PALYNZIQ® (pegvaliase-pqpz) Details Phenylketonuria | BLA Submission | |
VOXZOGO Details Hypochondroplasia | Phase 2 Data readout |